Title | The Year in Metabolism 1975-1976 [electronic resource] / edited by Norbert Freinkel |
---|---|
Imprint | Boston, MA : Springer US, 1976 |
Connect to | http://dx.doi.org/10.1007/978-1-4684-7656-9 |
Descript | XXI, 353 p. 26 illus. online resource |
1 Hormone Receptors, Cyclic Nucleotides, and Control of Cell Function -- 1.1. Introduction -- 1.2. Receptor Systems -- 1.3. Regulation of Adenylate Cyclase -- 1.4. Cyclic 3?,5?-Adenosine Monophosphate Concentration in Tissue and Protein Kinase Activation -- 1.5. Cyclic Nucleotides in the Extracellular Fluids -- References -- 2 Diabetes Mellitus -- 2.1. Introduction -- 2.2. Heterogeneity in Etiology and Pathogenesis -- 2.3. Measurement of Insulin Secretory Products -- 2.4. Acute Complications -- 2.5. Long-Term Complications -- References -- 3 Glucagon -- 3.1. Immunoreactive Glucagon in Tissues and Plasma -- 3.2. Glucagon MetabolismโClearance and Degradation -- 3.3. Actions of Glucagon on the Liver -- 3.4. Physiological Roles of Glucagon and Insulin in Fuel HomeostasisโThe Concept of a Bihormonal Unit -- 3.5. Proposed Mechanisms of Glucagon Action -- 3.6. Control of Glucagon Secretion -- 3.7. Studies of Glucagon Physiology Using Somatostatin -- 3.8. Microanatomical Organization of the Islets of Langerhans -- 3.9. Extrapancreatic Glucagon -- 3.10. Diabetes Mellitus -- 3.11. A-Cell Function in Prediabetes -- 3.12. Catabolic Diseases -- 3.13. Glucagonoma -- References -- 4 Recent Developments in Body Fuel Metabolism -- 4.1. Introduction -- 4.2. Glucose Metabolism -- 4.3. Protein and Amino Acid Metabolism -- 4.4. Fatty Acid and Ketone Metabolism -- 4.5. Fuel Metabolism in Exercise -- References -- 5 Recent Endocrine and Metabolic Investigations Relevant to Obesity -- 5.1. Introduction -- 5.2. Insulin -- 5.3. Thermogenesis and Thyroid Function -- 5.4. The Gastrointestinal Tract -- 5.5. Appetite and Substrate Utilization -- References -- 6 Disorders of Lipid and Lipoprotein Metabolism -- 6.1. Introduction -- 6.2. Lipoprotein Structure and Metabolism -- 6.3. HyperlipidemiasโDefinition and Classification -- 6.4. Familial Hypercholesterolemia -- 6.5. Type III Hyperlipoproteinemia -- 6.6. Familial Lecithin: Cholesterol Acyltransferase Deficiency -- 6.7. Chronic Renal Failure and Hyperlipidemia -- 6.8. Diabetes Mellitus and Hyperlipidemia -- 6.9. Treatment of Hyperlipidemia -- References -- 7 Metabolism of Amino Acids and Organic Acids -- 7.1. Introduction -- 7.2. Hyperammonemia and Urea Cycle Enzymes -- 7.3. Inherited Defects of Cobalamin (Vitamin B12) Metabolism -- 7.4. Use of Stable Isotopes in the Investigation of Disorders of Amino Acid and Organic Acid Metabolism -- References -- (Section 7.1) -- Hyperammonemia and Urea Cycle Enzymes (Section 7.2) -- Inherited Defects of Cobalamin Metabolism (Section 7.3) -- Stable Isotopes (Section 7.4) -- 8 Disorders of Purine and Pyrimidine Metabolism -- 8.1. Introduction -- 8.2. Abnormalities of Purine Metabolism -- 8.3. Abnormalities in Serum Urate Concentration -- 8.4. Abnormalities of Pyrimidine Metabolism -- 8.5. Regulatory Role of Cyclic Purine Nucleotides -- References -- 9 Whatโs NewโVitamins and Minerals -- 9.1. Introduction -- 9.2. Vitamin C -- 9.3. Vitamin D -- References -- 10 Nutrition, Growth, and Development -- 10.1. Introduction -- 10.2. Normal Nutrition -- 10.3. Abnormal Nutrition -- References -- 11 Metabolic Aspects of Renal Stone Disease -- 11.1. Introduction -- 11.2. Types of Renal Stones -- 11.3. Pathogenesis of Renal Stones -- 11.4. Treatment and Prevention of Renal Stones -- 11.5. Summary -- References -- 12 Metabolism and Metabolic Actions of Ethanol -- 12.1. Metabolism of Ethanol -- 12.2. The Hypermetabolic State Produced by Ethanol -- 12.3. Effects of Alcohol on the Liver and Development of Alcoholic Liver Injury -- 12.4. Interaction of Ethanol and Lipid Metabolism in Liver and Intestine -- 12.5. AcetaldehydeโIts Metabolism and Metabolic Effects -- References